These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7927219)

  • 1. Cysteinyl leukotrienes in the urine of patients with liver diseases.
    Uemura M; Buchholz U; Kojima H; Keppler A; Hafkemeyer P; Fukui H; Tsujii T; Keppler D
    Hepatology; 1994 Oct; 20(4 Pt 1):804-12. PubMed ID: 7927219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotrienes in the bile of patients with obstructive jaundice.
    Uemura M; Kojima H; Buchholz U; Kikuchi E; Matsumoto M; Kikukawa M; Imazu H; Fukui H; Tsujii T; Keppler D
    J Gastroenterol; 2002; 37(10):821-30. PubMed ID: 12424566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cysteinyl leukotrienes in human urine: enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome.
    Huber M; Kästner S; Schölmerich J; Gerok W; Keppler D
    Eur J Clin Invest; 1989 Feb; 19(1):53-60. PubMed ID: 2499462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography.
    Guhlmann A; Krauss K; Oberdorfer F; Siegel T; Scheuber PH; Müller J; Csuk-Glänzer B; Ziegler S; Ostertag H; Keppler D
    Hepatology; 1995 Jun; 21(6):1568-75. PubMed ID: 7768501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased excretion of endogenous urinary leukotriene E4 in extrahepatic cholestasis.
    Mayatepek E; Pecher G
    Clin Chim Acta; 1993 Sep; 218(2):185-92. PubMed ID: 8306442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication.
    Uemura M; Lehmann WD; Schneider W; Seitz HK; Benner A; Keppler-Hafkemeyer A; Hafkemeyer P; Kojima H; Fujimoto M; Tsujii T; Fukui H; Keppler D
    Gastroenterology; 2000 Jun; 118(6):1140-8. PubMed ID: 10833489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased production of cysteinyl leukotrienes in hepatorenal syndrome.
    Moore KP; Taylor GW; Maltby NH; Siegers D; Fuller RW; Dollery CT; Williams R
    J Hepatol; 1990 Sep; 11(2):263-71. PubMed ID: 2174935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis.
    Bouchelouche K; Kristensen B; Nordling J; Horn T; Bouchelouche P
    J Urol; 2001 Dec; 166(6):2121-5. PubMed ID: 11696719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased biliary secretion of cysteinyl-leukotrienes in human bile duct obstruction.
    Richter L; Hesselbarth N; Eitner K; Schubert K; Bosseckert H; Krell H
    J Hepatol; 1996 Nov; 25(5):725-32. PubMed ID: 8938552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary cysteinyl leukotrienes in one-year follow-up of percutaneous transluminal angioplasty for peripheral arterial occlusive disease.
    Maga P; Sanak M; Rewerska B; Maga M; Jawien J; Wachsmann A; Rewerski P; Szczeklik W; Celejewska-Wójcik N
    Atherosclerosis; 2016 Jun; 249():174-80. PubMed ID: 27105160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective hepatobiliary leukotriene elimination in patients with the Dubin-Johnson syndrome.
    Mayatepek E; Lehmann WD
    Clin Chim Acta; 1996 May; 249(1-2):37-46. PubMed ID: 8737590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and CCl4-induced liver injury, but not acidosis, impair metabolism of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Hepatology; 1990 May; 11(5):866-73. PubMed ID: 2161395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced urinary excretion of leukotriene E4 by patients with multiple trauma with or without adult respiratory distress syndrome.
    Fauler J; Tsikas D; Holch M; Seekamp A; Nerlich ML; Sturm J; Frölich JC
    Clin Sci (Lond); 1991 May; 80(5):497-504. PubMed ID: 1851691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased generation of cysteinyl leukotrienes in Kawasaki disease.
    Mayatepek E; Lehmann WD
    Arch Dis Child; 1995 Jun; 72(6):526-7. PubMed ID: 7618941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion.
    Huber M; Guhlmann A; Jansen PL; Keppler D
    Hepatology; 1987; 7(2):224-8. PubMed ID: 3030916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport and in vivo elimination of cysteinyl leukotrienes.
    Keppler D; Müller M; Klünemann C; Guhlmann A; Krauss K; Müller J; Berger U; Leier I; Mayatepek E
    Adv Enzyme Regul; 1992; 32():107-16. PubMed ID: 1496913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo.
    von Schacky C; Kiefl R; Jendraschak E; Kaminski WE
    J Lab Clin Med; 1993 Feb; 121(2):302-9. PubMed ID: 8381847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of sinusoidal uptake and biliary excretion of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1990 Jul; 191(1):251-5. PubMed ID: 2165907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma.
    Asano K; Lilly CM; O'Donnell WJ; Israel E; Fischer A; Ransil BJ; Drazen JM
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):643-51. PubMed ID: 7499681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.